Funding for this research was provided by:
National Cancer Institute (2P01CA095426-11, 2K12CA133250-11)
National Institute of General Medical Sciences (5T32GM068412-12)
National Center for Advancing Translational Sciences (UL1TR000090)
Received: 17 January 2020
Accepted: 11 May 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: Ethical approval of this study was obtained from The Ohio State University Comprehensive Cancer Center institutional review board (IRB protocol No. 2010C0036). All patients were required to sign a written, IRB-approved informed consent form prior to enrollment to participate in this study.
: Not applicable.
: The authors declare no commercial or financial conflict of interest.